<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03788967</url>
  </required_header>
  <id_info>
    <org_study_id>SPR994-301</org_study_id>
    <nct_id>NCT03788967</nct_id>
  </id_info>
  <brief_title>Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)</brief_title>
  <acronym>ADAPT-PO</acronym>
  <official_title>A Phase 3, Randomized, Double-blind, Double-dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spero Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spero Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The key purpose of this study is to evaluate the efficacy, safety and pharmacokinetics (PK)
      of TBPM-PI-HBr compared to IV ertapenem, in subjects with Complicated Urinary Tract Infection
      (cUTI) or Acute Pyelonephritis (AP).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 3, 2019</start_date>
  <completion_date type="Actual">May 27, 2020</completion_date>
  <primary_completion_date type="Actual">May 20, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with overall response (combined clinical cure plus microbiological eradication) at test-of-cure (TOC) in the micro- intent-to-treat (ITT) population</measure>
    <time_frame>Day 19 +/- 2 days</time_frame>
    <description>Clinical cure is defined as complete resolution or significant improvement of signs and symptoms of cUTI or AP that were present at baseline and no new symptoms, such that no further antimicrobial therapy is warranted.
Microbiological eradication is defined as reduction of baseline urine pathogen(s) to &lt;10^3 colony forming unit/milliliter (CFU/mL) and negative repeated blood culture if blood culture was positive for uropathogen growth at baseline.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1372</enrollment>
  <condition>Complicated Urinary Tract Infection</condition>
  <condition>Acute Pyelonephritis</condition>
  <arm_group>
    <arm_group_label>TBPM-PI-HBr 300 mg film-coated tablets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TBPM-PI-HBr 600 mg administered orally three times per day for 7 to 10 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ertapenem</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ertapenem for IV injection administered as a 1-gram IV infusion over 30 min once daily for 7 to 10 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr)</intervention_name>
    <description>Antibiotic Therapy for Complicated Urinary Tract Infection</description>
    <arm_group_label>TBPM-PI-HBr 300 mg film-coated tablets</arm_group_label>
    <other_name>SPR994</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ertapenem</intervention_name>
    <description>Antibiotic Therapy for Complicated Urinary Tract Infection</description>
    <arm_group_label>Ertapenem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Male and female subjects at least 18 years of age

          2. Able to provide informed consent

          3. Able to ingest oral tablets for the anticipated treatment duration

          4. Have a diagnosis of cUTI or AP as defined below:

             a. cUTI definition:

             At least Two of the following signs and symptoms:

             i. Chills, rigors, or fever; fever must be observed and documented by a health care
             provider (oral, tympanic, rectal or core temperature &gt;38.0°C [&gt;100.4°F])

             ii. Dysuria, urgency to void, or increased urinary frequency

             iii. Nausea or vomiting, as reported by the subject

             iv. Lower abdominal, suprapubic, or pelvic pain

             And at least One of the following risk factors for cUTI:

             i. Implanted urinary tract instrumentation (e.g., nephrostomy tube, ureteric stents,
             or other urinary tract prosthetic material), ongoing intermittent bladder
             catheterization, or presence of an indwelling bladder catheter (Note: bladder
             catheters that have been in place for &gt;24 hours prior to Screening must be removed or
             replaced prior to collection of the Screening urine for urinalysis and culture, unless
             removal or replacement is considered unsafe or contraindicated)

             ii. Current known functional or anatomical abnormality of the urogenital tract,
             including anatomic abnormalities of the urinary tract, neurogenic bladder, or
             post-void residual urine volume of ≥ 100 mL within the past 6 months

             iii. Complete or partial obstructive uropathy (e.g., nephrolithiasis, tumor, fibrosis,
             urethral stricture) that is expected to be medically or surgically treated during
             study drug therapy (prior to EOT)

             iv. Known intrinsic renal disease with blood urea nitrogen (BUN) &gt;20 mg/deciliter
             (dL), or blood urea &gt;42.8 mg/dL, or serum creatinine (Cr) &gt;1.4 mg/dL

             v. Urinary retention, including urinary retention in men due to previously diagnosed
             benign prostatic hyperplasia (BPH)

             b. AP definition: Acute flank pain (onset within 7 days prior to randomization) or
             costovertebral angle tenderness on physical examination.

             And at least One of the following signs and symptoms:

             i. Chills, rigors, or fever; fever must be observed and documented by a health care
             provider (oral, tympanic, rectal or core temperature &gt;38.0°C [&gt;100.4°F])

             ii. Peripheral white blood cell count (WBC) &gt;10,000/mm3 or bandemia (≥15% immature
             polymorphonuclear neutrophils (PMNs), regardless of WBC count)

             iii. Nausea or vomiting, as reported by the subject

             iv. Dysuria, urgency to void, or increased urinary frequency

             Note: Subjects who meet the definition for cUTI (Inclusion Criterion 4a) and also have
             flank pain or costovertebral tenderness should be randomized as cUTI rather than AP.

          5. Have an adequate urine specimen for evaluation and culture obtained within 24 h prior
             to randomization with evidence of pyuria that includes at least one of the following:

               1. At least 10 WBCs per high power field (hpf) in urine sediment

               2. At least 10 WBCs per cubic millimeter (mm3) in unspun (non centrifuged) urine

               3. Positive leukocyte esterase (LE) on urinalysis

             Note: Subjects may be randomized and administered investigational product (IP) prior
             to knowledge of urine culture results.

          6. Expectation, in the judgment of the Investigator, that the subject will survive with
             effective antibiotic therapy and appropriate supportive care for the anticipated
             duration of the study

          7. Willing to comply with all the study activities and procedures throughout the duration
             of the study

          8. Subjects must agree to use a highly-effective method of birth control; male subjects
             must agree to use an effective barrier method of contraception from Screening through
             late follow-up (LFU) and for 90 days following the last dose if sexually active with a
             female of childbearing potential (FOCP); female subjects must not be pregnant or
             nursing, and must commit to either sexual abstinence or use at least two medically
             accepted, effective methods of birth control (e.g., condom, spermicidal gel, oral
             contraceptive, indwelling intrauterine device, hormonal implant/patch, injections,
             approved cervical ring) from Screening through LFU and for 90 days following the last
             dose.

        Exclusion Criteria

          1. Presence of any known or suspected disease or condition that, in the opinion of the
             Investigator, may confound the assessment of efficacy, including but not limited to
             the following:

               1. Perinephric or renal corticomedullary abscess

               2. Uncomplicated urinary tract infection (uUTI) - (acute cystitis that does not meet
                  the cUTI disease definition, see Inclusion Criterion 4a)

               3. Polycystic kidney disease

               4. Recent history of trauma to the pelvis or urinary tract

               5. Confirmed or suspected acute or chronic bacterial prostatitis, orchitis, or
                  epididymitis

               6. Chronic vesicoureteral reflux

               7. Previous or planned renal transplantation

               8. Previous or planned cystectomy or ileal loop surgery

               9. Known or suspected non-renal source of infection (e.g., infective endocarditis,
                  osteomyelitis, meningitis, pneumonia)

              10. Confirmed or suspected infection that is caused by a pathogen that is resistant
                  to either IP (e.g., carbapenem-resistant pathogen), including infection caused by
                  fungi (e.g., candiduria) or mycobacteria (e.g., urogenital tuberculosis)

          2. Gross hematuria requiring intervention other than administration of IP or
             removal/placement of urinary tract instrumentation

          3. Urinary tract surgery within 7 days prior to randomization or urinary tract surgery
             planned during the study period (except surgery required relieving an obstruction or
             placing urinary tract instrumentation)

          4. Creatinine clearance (CrCl) of &lt;50 mL/min, as estimated by the Cockcroft-Gault
             formula:

             estimated Creatinine Clearance (eC_Cr) [mL/min]=((140-Age [yrs]) × Body Weight [kg] ×
             [0.85 if Female])/(72 × Serum Creatinine [mg⁄dL])

          5. Anticipated concomitant use of non-study antibacterial drug therapy between
             randomization and the LFU Visit that would potentially effect outcome evaluations of
             cUTI/ AP, including but not limited to antibacterials with potential activity versus
             uropathogens, antibacterial drug prophylaxis, and antibacterial bladder irrigation

          6. Anticipated concomitant use of gastric acid-reducing medications between randomization
             and end-of-treatment (EOT), including proton pump inhibitors, histamine-2 receptor
             antagonists, and antacids

          7. Receipt of more than a single dose of a short-acting potentially effective antibiotic
             within 72 h prior to randomization; no more than 25% of subjects will be enrolled who
             meet the above criterion

             Exception: Subjects who received more than a single dose of short-acting potentially
             effective antibiotic within 72 h prior to randomization may be eligible for enrollment
             if they meet all of the following criteria:

               1. In the opinion of the Investigator they have failed the prior antibiotic therapy
                  (e.g., have worsening signs and symptoms of cUTI/AP)

               2. Have a documented uropathogen (growth in urine culture &gt;105 CFU/mL) that is
                  resistant to the prior antibiotic therapy

               3. Have a documented uropathogen that is carbapenem-susceptible

               4. Receives approval from the Medical Monitor to enroll the subject

          8. Severe hepatic impairment at Screening, as evidenced by alanine aminotransferase (ALT)
             or aspartate aminotransferase (AST) &gt;5x upper limit of normal (ULN) or total bilirubin
             &gt;3x ULN, or clinical signs of cirrhosis or end-stage hepatic disease (e.g., ascites,
             hepatic encephalopathy)

          9. Any signs of severe sepsis, including shock or profound hypotension defined as
             systolic blood pressure &lt;90 mmHg or a decrease of &gt;40 mmHg from baseline that is not
             responsive to fluid challenge

         10. Pregnant or breastfeeding women

         11. History of epilepsy or known seizure disorder (excluding a history of childhood
             febrile seizures)

         12. Receipt of any investigational medication during the last 30 days or 5 half-lives,
             whichever is longer, prior to randomization

         13. Known history of human immunodeficiency virus (HIV) infection or acquired
             immunodeficiency syndrome (AIDS)-defining illness, or known cluster of differentiation
             4 (CD4) count &lt;200/mm3 within the past year

         14. Presence of immunodeficiency or an immunocompromised condition including neutropenia
             (&lt;1,000 neutrophils/mm3 obtained from the local laboratory at Screening), hematologic
             malignancy, bone marrow transplant, or receiving immunosuppressive therapy such as
             cancer chemotherapy, medications for the rejection of transplantation, and long term
             use of systemic corticosteroids (e.g., ≥20 mg/day of prednisone or systemic equivalent
             for at least 2 weeks)

         15. A mean QT interval corrected using Fridericia's formula (QTcF) &gt;480 msec based on
             triplicate ECGs at Screening

         16. History of significant hypersensitivity or allergic reaction to β-lactam antibiotics
             (e.g., cephalosporins, penicillins, carbapenems), product excipients (Mannitol,
             microcrystalline cellulose, crospovidone, magnesium stearate, colloidal silicon
             dioxide, and Opadry) or any contraindication to the use of ertapenem

         17. History of known genetic metabolism anomaly associated with carnitine deficiency
             (e.g., carnitine transporter defect, methylmalonic aciduria, propionic acidemia)

         18. Requirement for concomitant use of valproic acid, divalproex sodium, or probenecid
             between randomization and EOT

         19. Unable or unwilling to comply with the protocol

         20. An employee of the Investigator or study center with direct involvement in the
             proposed study or other studies under the direction of that Investigator or study
             center, as well as a family member of the employee or the Investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Melnick, MD</last_name>
    <role>Study Director</role>
    <affiliation>Spero Therapeutics, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Blagoevgrad</city>
        <zip>2700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Dobrich</city>
        <zip>9300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Ruse</city>
        <zip>7000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Shumen</city>
        <zip>9700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Veliko Tarnovo</city>
        <zip>5000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Karlovy Vary</city>
        <zip>360 66</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Liberec</city>
        <zip>460 63</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Prague</city>
        <zip>140 59</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Zlin</city>
        <zip>762 75</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Ústí Nad Labem</city>
        <zip>401 13</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Kohtla-Jarve</city>
        <zip>31025</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Tallinn</city>
        <zip>10617</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Voru</city>
        <zip>65526</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Tbilisi</city>
        <zip>0144</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Tbilisi</city>
        <zip>0160</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Tbilisi</city>
        <zip>0172</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Zestap'oni</city>
        <zip>2000</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Budapest</city>
        <zip>H-1082</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Budapest</city>
        <zip>H-1204</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Nagykanizsa</city>
        <zip>H-8800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Nyíregyháza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Tatabánya</city>
        <zip>2800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Riga</city>
        <zip>LV-1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Riga</city>
        <zip>LV-1038</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Valmiera</city>
        <zip>LV-4201</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Chisinau</city>
        <zip>MD-2004</zip>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Chisinau</city>
        <zip>MD2025</zip>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Katowice</city>
        <zip>40-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Kraków</city>
        <zip>31-559</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Oswiecim</city>
        <zip>32-600</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Wrocław</city>
        <zip>51-162</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Łódź</city>
        <zip>90-153</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Bucharest</city>
        <zip>021494</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Bucharest</city>
        <zip>050659</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Craiova</city>
        <zip>200642</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Iaşi</city>
        <zip>700503</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Oradea</city>
        <zip>410469</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Arkhangelsk</city>
        <zip>163001</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Lomonosov</city>
        <zip>198412</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Penza</city>
        <zip>440026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Pyatigorsk</city>
        <zip>357500</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>191186</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>194017</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>194044</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>194064</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>195009</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>195067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196247</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197374</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>198205</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical facility</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Smolensk</city>
        <zip>214019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Smolensk</city>
        <zip>214025</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Vsevolozhsk</city>
        <zip>188643</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Belgrad</city>
        <zip>11 000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Kragujevac</city>
        <zip>34 000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Novi Sad</city>
        <zip>21 000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Vršac</city>
        <zip>26300</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Bratislava</city>
        <zip>826 06</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Galanta</city>
        <zip>924 22</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Lučenec</city>
        <zip>984 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Martin</city>
        <zip>03659</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Poprad</city>
        <zip>05845</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Svidník</city>
        <zip>089 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Benoni</city>
        <zip>1500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Chatsworth</city>
        <zip>4092</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Durban</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Johannesburg</city>
        <zip>2013</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Middelburg</city>
        <zip>1050</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Pretoria</city>
        <zip>0001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Cherkasy</city>
        <zip>18009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Chernihiv</city>
        <zip>14034</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Dnipro</city>
        <zip>49027</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Ivano-Frankivs'k</city>
        <zip>76008</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Ivano-Frankivs'k</city>
        <zip>76018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Kharkiv</city>
        <zip>61037</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Kharkiv</city>
        <zip>61103</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Lviv</city>
        <zip>79010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Lviv</city>
        <zip>79059</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Mykolaiv</city>
        <zip>54058</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Odesa</city>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Odesa</city>
        <zip>65074</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Uzhhorod</city>
        <zip>88000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Zaporizhia</city>
        <zip>69600</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Facility</name>
      <address>
        <city>Zhytomyr</city>
        <zip>10002</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Georgia</country>
    <country>Hungary</country>
    <country>Latvia</country>
    <country>Moldova, Republic of</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 22, 2018</study_first_submitted>
  <study_first_submitted_qc>December 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2018</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Complicated Urinary Tract Infection</keyword>
  <keyword>Acute Pyelonephritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Pyelonephritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ertapenem</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

